Laryngotracheoesophageal cleft type 0

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:280205Q32.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Laryngotracheoesophageal cleft type 0 (LTEC type 0), also known as a laryngeal cleft type 0 or submucous laryngeal cleft, is the mildest form of laryngeal cleft, a group of rare congenital malformations affecting the posterior larynx and the partition between the airway and the esophagus (digestive tract). In type 0, the cleft is limited to a deficiency in the interarytenoid muscle above the level of the vocal folds, with the overlying mucosa remaining intact (submucous cleft). This distinguishes it from more severe types (types I–IV) where the cleft extends deeper into the larynx, trachea, or esophagus. Because the defect is subtle and the mucosa appears intact on standard examination, type 0 clefts can be difficult to diagnose and are often underrecognized. The primary body systems affected are the respiratory and gastrointestinal systems. Key clinical features include chronic cough, recurrent aspiration, aspiration pneumonia, feeding difficulties, dysphagia (difficulty swallowing), stridor, and a hoarse or weak cry in infants. Symptoms often overlap with other causes of pediatric aspiration, such as laryngomalacia or gastroesophageal reflux, which can delay diagnosis. Diagnosis typically requires a high index of clinical suspicion and is confirmed through microlaryngoscopy and bronchoscopy, often with palpation of the interarytenoid area to detect the muscular deficiency beneath intact mucosa. Management depends on symptom severity. Conservative measures include thickening of feeds, anti-reflux therapy, and swallowing therapy. In cases with persistent aspiration despite conservative management, surgical intervention with injection laryngoplasty (injection of a filler material into the interarytenoid area to improve the barrier between the airway and esophagus) has been reported as an effective treatment. Prognosis is generally favorable, particularly when the condition is identified and managed early.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Laryngotracheoesophageal cleft type 0.

View clinical trials →

No actively recruiting trials found for Laryngotracheoesophageal cleft type 0 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Laryngotracheoesophageal cleft type 0 community →

No specialists are currently listed for Laryngotracheoesophageal cleft type 0.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Laryngotracheoesophageal cleft type 0.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Laryngotracheoesophageal cleft type 0Forum →

No community posts yet. Be the first to share your experience with Laryngotracheoesophageal cleft type 0.

Start the conversation →

Latest news about Laryngotracheoesophageal cleft type 0

No recent news articles for Laryngotracheoesophageal cleft type 0.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Laryngotracheoesophageal cleft type 0

What is Laryngotracheoesophageal cleft type 0?

Laryngotracheoesophageal cleft type 0 (LTEC type 0), also known as a laryngeal cleft type 0 or submucous laryngeal cleft, is the mildest form of laryngeal cleft, a group of rare congenital malformations affecting the posterior larynx and the partition between the airway and the esophagus (digestive tract). In type 0, the cleft is limited to a deficiency in the interarytenoid muscle above the level of the vocal folds, with the overlying mucosa remaining intact (submucous cleft). This distinguishes it from more severe types (types I–IV) where the cleft extends deeper into the larynx, trachea, or

How is Laryngotracheoesophageal cleft type 0 inherited?

Laryngotracheoesophageal cleft type 0 follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Laryngotracheoesophageal cleft type 0 typically begin?

Typical onset of Laryngotracheoesophageal cleft type 0 is neonatal. Age of onset can vary across affected individuals.